These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21944027)

  • 21. [Diagnosis and treatment of cystic fibroadenomatosis and its relationship to breast carcinoma].
    Shegortsova IG
    Vopr Onkol; 1979; 25(7):109-15. PubMed ID: 483673
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Breast cancer: major therapeutic advances but mortality remains high].
    Pierga JY
    Rev Prat; 2013 Dec; 63(10):1359-61. PubMed ID: 24579328
    [No Abstract]   [Full Text] [Related]  

  • 24. Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases.
    Wang X; Zhang W; Xu Z; Luo Y; Mitchell D; Moss RW
    Integr Cancer Ther; 2009 Sep; 8(3):283-7. PubMed ID: 19815599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
    Johnston SR
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of symptom directed evaluation in the surveillance for recurrence of carcinoma of the breast.
    Wagman LD; Sanders RD; Terz JJ; Beatty JD; Kokal WA; Riihimaki DU
    Surg Gynecol Obstet; 1991 Mar; 172(3):191-6. PubMed ID: 1994495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
    Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
    Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current standards and new trends in the primary treatment of colorectal cancer.
    Stein A; Atanackovic D; Bokemeyer C
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S312-4. PubMed ID: 21943995
    [No Abstract]   [Full Text] [Related]  

  • 30. Changing patterns in the management of locally advanced breast cancer: a preliminary report.
    Lopez MJ; Kraybill WG; Reynolds RD; Khojasteh A
    Can J Surg; 1985 Jul; 28(4):319-21. PubMed ID: 4016605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of contemporary management of breast carcinoma.
    Suhrland LG
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):783-96. PubMed ID: 3323974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast carcinoma: state of the art].
    Pestalozzi BC
    Schweiz Med Wochenschr; 1996 Nov; 126(48):2049-58. PubMed ID: 8992624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory cancer of the breast. Therapy and follow-up].
    Volz J; Volz E; Böhm W; Schneider V
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):206-9. PubMed ID: 1607113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
    Dizdar O; Aksoy S; Altundag K
    Ann Oncol; 2009 Jan; 20(1):189; author reply 189-90. PubMed ID: 18820244
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.
    Weide R; Mergenthaler U; Pandorf A; Arndt H; Heymanns J; Thomalla J; Köppler H
    Onkologie; 2009 Mar; 32(3):107-13. PubMed ID: 19295249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies in the detection and treatment of breast cancer micrometastases.
    Neville AM; Monaghan P; McIlhinney RA; Gusterson B; Coombes RC
    Monogr Pathol; 1986; (27):193-205. PubMed ID: 3762554
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
    Sidorova NA; Volchenko NN; Saribekian EK
    Sov Med; 1991; (11):15-8. PubMed ID: 1662831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy.
    Kuru B
    Singapore Med J; 2011 Apr; 52(4):289-98. PubMed ID: 21552792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer--new and emerging technologies for diagnosis and management.
    Houssami N; French J; Brennan M; Ahern V; Ung O
    Aust Fam Physician; 2005 Aug; 34(8):657-61. PubMed ID: 16113703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.